Andrew A. Nierenberg, Peter Margolis, Stephen Strakowski, Madhukar Trivedi, Lakshmi N. Yatham, Bipolar Disorder Learning Health Network
doi : 10.1111/bdi.13339
Eline M. P. Poels, Astrid M. Kamperman, Hilmar H. Bijma, Adriaan Honig, Inge L. van Kamp, Steven A. Kushner, Witte J. G. Hoogendijk, Veerle Bergink, Tonya White
doi : 10.1111/bdi.13297
Lithium is often continued during pregnancy to reduce the risk of perinatal mood episodes for women with bipolar disorder. However, little is known about the effect of intrauterine lithium exposure on brain development. The aim of this study was to investigate brain structure in children after intrauterine exposure to lithium.
Ian B. Hickie, Kathleen R. Merikangas, Joanne S. Carpenter, Frank Iorfino, Elizabeth M. Scott, Jan Scott, Jacob J. Crouse
doi : 10.1111/bdi.13304
Emerging evidence suggests a role of circadian dysrhythmia in the switch between “activation� states (i.e., objective motor activity and subjective energy) in bipolar I disorder.
Rebekah S. Huber, Danielle Boxer, Calen J. Smith, Perry F. Renshaw, Deborah A. Yurgelun-Todd, Douglas G. Kondo
doi : 10.1111/bdi.13294
There is a critical need to better understand the factors underlying the increased suicide risk for youth with bipolar disorder (BD) in order to develop targeted prevention efforts. This study aimed to examine differences in characteristics of suicide ideation (SI) in youth with BD compared to youth with major depressive disorder (MDD) that may be associated with increased suicide risk.
Gin S. Malhi, Pritha Das, Tim Outhred, Erica Bell, Danielle Gessler, Richard Bryant, Zola Mannie
doi : 10.1111/bdi.13286
Childhood trauma is deleterious to long term brain development. The changes are variable, and depend on gender, age and the nature of the trauma. In this exploratory analysis, we investigated the effects of exposure to emotional trauma on grey matter (GM) volumes in adolescent females.
William S. H. Kim, Mikaela K. Dimick, Danielle Omrin, Rachel H. B. Mitchell, Daniel Riegert, Anthony Levitt, Ayal Schaffer, Susan Belo, John Iazzetta, Garfield Detzler, Mabel Choi, Stephen Choi, Nathan Herrmann, Roger S. McIntyre, Bradley J. MacIntosh, Beverley A. Orser, Benjamin I. Goldstein
doi : 10.1111/bdi.13288
There remain few efficacious treatments for bipolar depression, which dominates the course of bipolar disorder (BD).
Giovanni Martinotti, Bernardo Dell'Osso, Giorgio Di Lorenzo, Giuseppe Maina, Alessandro Bertolino, Massimo Clerici, Stefano Barlati, Gianluca Rosso, Marco Di Nicola, Matteo Marcatili, Giacomo d'Andrea, Clara Cavallotto, Stefania Chiappini, Sergio De Filippis, Giuseppe Nicolò, Pasquale De Fazio, Ileana Andriola, Raffaella Zanardi, Domenica Nucifora, Stefania Di Mauro, Roberta Bassetti, Mauro Pettorruso, Roger S. McIntyre, Stefano L. Sensi, Massimo di Giannantonio, Antonio Vita, the REAL-ESK Study Group
doi : 10.1111/bdi.13296
Bipolar depression accounts for most of the disease duration in type I and type II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals do not respond to first-line therapeutic options, resulting in treatment-resistant bipolar depression (B-TRD). Esketamine, the S-enantiomer of ketamine, has recently been approved for treatment-resistant depression (TRD), but no data are available on its use in B-TRD.
Mikaela K. Dimick
doi : 10.1111/bdi.13279
Balwinder Singh
doi : 10.1111/bdi.13324
Simran Arora, Preethi V. Reddy, Geetha Desai, Muralidharan Kesavan, Prabha S. Chandra
doi : 10.1111/bdi.13314
Hanna Tu, Eva Pilato, Pascal Sienaert
doi : 10.1111/bdi.13292
Verinder Sharma, Malak Al-Farayedhi
doi : 10.1111/bdi.13303
Do you want to add Medilib to your home screen?